Propeller Health Launches My Pharmacy
Propeller Health has launched My Pharmacy, a feature on its app that connects Propeller users living with asthma and chronic obstructive pulmonary disease (COPD) directly to pharmacy services, the company…
Category Archives: Biotech
FCDI Launches iCell Microglia
FUJIFILM Cellular Dynamics Inc. (FCDI) has launched iCell Microglia, the company announced today. According to a release, iCell Microglia will be used in life science research to enable the study…
Exact Sciences Releases Q4 Stats
Exact Sciences recently announced its fourth quarter numbers, which included revenues between $142.5 million – $143.5 million and 292,000 completed Cologuard tests, an increase of 64 percent and 66 percent…
FCDI to Open New Madison Facility
FUJIFILM Cellular Dynamics Inc. (FCDI) has plans to open a $21 million production facility in Madison to industrialize iPS cell manufacturing for regenerative medicine therapies, the company announced today. “To meet the…
Semba Biosciences to be Acquired
Semba Biosciences announced recently that it received an equity investment from Tosoh Bioscience, which intends to acquire the company, though no additional details were provided. According to a release, the two…
Cellectar’s CLR 131 Granted Japanese Patent
Cellectar Biosciences has received a patent for CLR 131 by the Japan Patent Office, the company announced recently. “Certain cancers such as pediatric lymphomas and leukemias have a higher prevalence…
Propeller Health Acquired by ResMed
Propeller Health is being acquired by ResMed, a health company based in San Diego that specializes in cloud-connected medical devices and out-of-hospital software-as-a-service business solutions, the company announced today. “ResMed shares…
SHINE Receives $150M in Funding
SHINE Medical Technologies, received $150 million in funding from Deerfield Management Company, a healthcare investment firm, to support diagnostic and therapeutic medical isotope manufacturing, the company announced recently. According to…
Exact Sciences Sees Growth in Tests
Exact Sciences recently announced its third quarter numbers, which included revenue of $118.3 million and 240,000 completed Cologuard tests, an increase of 63 percent and 49 percent, respectively. “The Exact…
Exact Sciences Acquires Biomatrica
Exact Sciences strengthened its pipeline capabilities with its acquisition of Biomatrica, a provider of biological sample preservation technology, the company announced today. “To detect cancer at its earliest stages, you need…
